Company / Current Assets per Share
Gain Therapeutics, Inc. Current Assets per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.72
FY2024
5-year range
$0.72 / $10.65
FY2021-FY2024
Trend
-52.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $10.65 in FY2021 to $0.72 in FY2024.
Based on SEC 10-K filings.
0.72 in FY2024 with a 3-year CAGR of -59.3%.
Declined from $1.77 to $0.72 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -59.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Gain Therapeutics, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2024, current assets per share decreased 52.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.72 | -52.1% |
| FY2023 | $1.50 | -15.7% |
| FY2022 | $1.77 | -83.3% |
| FY2021 | $10.65 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026